Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern mozambique
Infect. dis. obstet. gynecol
; 2010(609315): [1-9], Jun. 2020. tab, graf
Article
in English
| RSDM
| ID: biblio-1526770
Responsible library:
MZ1.1
ABSTRACT
There is limited information on the prevalence of sexually transmitted infections and the prevalence of cervical neoplasia in rural sub-Saharan Africa. This study describes the prevalence and the etiology of STIs and the prevalence of cervical neoplasia among women in southern Mozambique. An age-stratified cross-sectional study was performed where 262 women aged 14 to 61 years were recruited at the antenatal clinic (59%), the family-planning clinic (7%), and from the community (34%). At least one active STI was diagnosed in 79% of women. Trichomonas vaginalis was present in 31% of all study participants. The prevalence of Neisseria gonorrhea and Chlamydia trachomatis were 14% and 8%, respectively, and Syphilis was diagnosed in 12% of women. HPV DNA was detected in 40% of women and cervical neoplasia was diagnosed in 12% of all women. Risk factors associated with the presence of some of the STIs were being divorced or widowed, having more than one sexual partner and having the partner living in another area. A higher prevalence was observed in the reproductive age group and some of the STIs were more frequently diagnosed in pregnant women. STI control programs are a priority to reduce the STIs burden, including HIV and cervical neoplasia.
Full text:
Available
Collection:
National databases
/
MZ
Database:
RSDM
Main subject:
Rural Population
/
Sexually Transmitted Diseases, Bacterial
/
Sexually Transmitted Diseases
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Pregnancy
Country/Region as subject:
Africa
Language:
English
Journal:
Infect. dis. obstet. gynecol
Year:
2020
Document type:
Article
Institution/Affiliation country:
Cancer epidemiology research program. institut català d'oncologia (ico). Institute d'investigació biomèdica (idibell). l'hospitalet de llobregat/ES
/
Hospital clinic. institut d'investigacions biomedicas. Center for international health research (cresib). Universitat de Barcelona/ES
/
L'hospitalet de llobregat. Institut català d'oncologia (ico). Institut d'investigació biomèdica (idibell). Center epidemiology research program/ES
/
L'hospitalet de llobregat. Cancer epidemiology research program, Institut d'investigació biomèdica (idibell). Institut català d'oncologia (ico)/ES
/
L'hospitalet de llobregat. Cancer epidemiology research program. Institut català d'oncologia (ico), Institut d'investigació biomèdica (idibell)/ES
/
Manhiça health research center/MZ
/
Roche molecular systems/US